Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BBIO | Common Stock | Award | $0 | +19K | +4.81% | $0.00 | 414K | Aug 6, 2024 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BBIO | Stock Option (Right to Buy) | Award | $0 | +3.16K | $0.00 | 3.16K | Aug 6, 2024 | Common Stock | 3.16K | $24.87 | Direct | F3 |
Id | Content |
---|---|
F1 | Grant of restricted stock units (RSUs) under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest in 16 quarterly installments beginning on August 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. |
F2 | Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. |
F3 | The stock option shall vest in 16 quarterly installments beginning on August 16, 2024, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. |